Skip to content
Novartis is considering an offer for U.S. biotechnology firm The Medicines Co, Bloomberg reported on Tuesday, a deal that could broaden the Swiss drugmaker's cabinet of heart medicines and shore up growth threatened by patent expirations. Novartis, which declined to comment on the report, is hunting for a $5 billion acquisition in the United States, two banking sources told Reuters separately without identifying a target. New Jersey-based The Medicines Co's top drug candidate is cholesterol-lowering drug inclisiran for heart patients....
The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that......
If you want to know who really controls Occidental Petroleum Corporation (NYSE:OXY), then you'll have to look at the......
Investing.com – Oil is going down like a stone as the market is waking up to the hollow talk around the U.S.-China trade deal....
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story......
It's not possible to invest over long periods without making some bad investments. But really big losses can really......
The big shareholder groups in Orchid Island Capital, Inc. (NYSE:ORC) have power over the company. Generally speaking......
